Fayez Sarofim & Co
AGN

Fayez Sarofim & Co’s Allergan plc AGN Stock Holding History

Fayez Sarofim & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-824
Closed -$200K – 247
2017
Q2 		$200K Buy
+824
New +$194K ﹤0.01% 240
2016
Q4 		– Sell
-1,129
Closed -$260K – 248
2016
Q3 		$260K Sell
1,129
-1,057
-48% -$258K ﹤0.01% 228
2016
Q2 		$505K Sell
2,186
-174
-7% -$40.1K ﹤0.01% 176
2016
Q1 		$633K Buy
2,360
+38
+2% +$10.9K ﹤0.01% 162
2015
Q4 		$726K Sell
2,322
-44
-2% -$13.1K ﹤0.01% 155
2015
Q3 		$643K Hold
2,366
– – ﹤0.01% 162
2015
Q2 		$718K Buy
+2,366
New +$706K ﹤0.01% 159

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Fayez Sarofim & Co's AGN Position: Q3 2017 in Review

Fayez Sarofim & Co sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 824 shares — an estimated $200K sold.

Fayez Sarofim & Co first reported a position in AGN in Q2 2015 and held it in 7 quarters. The position peaked at $726K in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Fayez Sarofim & Co reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Fayez Sarofim & Co sold 824 Allergan plc shares in Q3 2017, an estimated $200K.
  • Fayez Sarofim & Co first reported a position in Allergan plc in Q2 2015 and held it in 7 quarters.
  • Fayez Sarofim & Co's Allergan plc position peaked at $726K in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Fayez Sarofim & Co's 13F filing for Q3 2017, filed 8 Nov 2017.